Atıf Formatları
Profile of psychotropic agents used in autism spectrum disorder according to comorbidities in Turkey: A 4-year evaluation
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Y. Karabacak Et Al. , "Profile of psychotropic agents used in autism spectrum disorder according to comorbidities in Turkey: A 4-year evaluation," International clinical psychopharmacology , vol.38, no.4, pp.216-222, 2023

Karabacak, Y. Et Al. 2023. Profile of psychotropic agents used in autism spectrum disorder according to comorbidities in Turkey: A 4-year evaluation. International clinical psychopharmacology , vol.38, no.4 , 216-222.

Karabacak, Y., BARUN, S., Vural, İ. M., VURAL, E. H., İŞERİ, E., Kahve, A. C., ... Yilmaz, E. Ş.(2023). Profile of psychotropic agents used in autism spectrum disorder according to comorbidities in Turkey: A 4-year evaluation. International clinical psychopharmacology , vol.38, no.4, 216-222.

Karabacak, Yurdum Et Al. "Profile of psychotropic agents used in autism spectrum disorder according to comorbidities in Turkey: A 4-year evaluation," International clinical psychopharmacology , vol.38, no.4, 216-222, 2023

Karabacak, Yurdum Et Al. "Profile of psychotropic agents used in autism spectrum disorder according to comorbidities in Turkey: A 4-year evaluation." International clinical psychopharmacology , vol.38, no.4, pp.216-222, 2023

Karabacak, Y. Et Al. (2023) . "Profile of psychotropic agents used in autism spectrum disorder according to comorbidities in Turkey: A 4-year evaluation." International clinical psychopharmacology , vol.38, no.4, pp.216-222.

@article{article, author={Yurdum Karabacak Et Al. }, title={Profile of psychotropic agents used in autism spectrum disorder according to comorbidities in Turkey: A 4-year evaluation}, journal={International clinical psychopharmacology}, year=2023, pages={216-222} }